Although significant advances in malaria control have been made in the past few decades, resistance to our current antimalarial drug repertoire threatens control efforts.
PhD Candidate Pamodha Somasiri of the Verma Group, RSB, BSB gives his Exit Seminar - The use of Caenorhabditis elegans as a potential animal model to study the pathogenesis of Shigella flexneri.